Capital Investment Advisory Services, LLC - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 78 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.0%.

Quarter-by-quarter ownership
Capital Investment Advisory Services, LLC ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$7,000
-36.4%
8980.0%0.00%
-33.3%
Q2 2019$11,000
+120.0%
8980.0%0.00%
+50.0%
Q1 2019$5,000
+400.0%
898
+125.6%
0.00%
Q4 2018$1,0003980.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
AdvisorShares Investments LLC 610,045$2,014,0000.47%
ETF MANAGERS GROUP, LLC 1,814,328$5,987,0000.13%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 72,169$238,0000.06%
Bernardo Wealth Planning LLC 27,219$89,0000.03%
Affinity Asset Advisors, LLC 13,285$44,0000.02%
ALGERT GLOBAL LLC 20,778$69,0000.02%
ZEKE CAPITAL ADVISORS, LLC 49,700$164,0000.01%
Founders Capital Management 2,000$18,0000.01%
King Wealth Management Group 16,000$53,0000.01%
Penserra Capital Management LLC 129,252$425,0000.01%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders